HUP0002539A2 - Gasztrokinetikus hatású 3- vagy 4-szubsztituált 4-(amino-metil)-piperidin-származékok biciklusos benzamidjai, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents
Gasztrokinetikus hatású 3- vagy 4-szubsztituált 4-(amino-metil)-piperidin-származékok biciklusos benzamidjai, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0002539A2 HUP0002539A2 HU0002539A HUP0002539A HUP0002539A2 HU P0002539 A2 HUP0002539 A2 HU P0002539A2 HU 0002539 A HU0002539 A HU 0002539A HU P0002539 A HUP0002539 A HU P0002539A HU P0002539 A2 HUP0002539 A2 HU P0002539A2
- Authority
- HU
- Hungary
- Prior art keywords
- alkyl
- optionally substituted
- amino
- halo
- alk
- Prior art date
Links
- -1 bicyclic benzamides Chemical class 0.000 title abstract 4
- 229940054066 benzamide antipsychotics Drugs 0.000 title 1
- 230000002640 gastrokinetic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 21
- 125000001475 halogen functional group Chemical group 0.000 abstract 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 6
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 abstract 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 2
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 abstract 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 abstract 1
- FOUUNSGQVBGYQM-SUMWQHHRSA-N 4-amino-5-chloro-n-[[(3s,4s)-3-hydroxy-1-(3-methoxypropyl)piperidin-4-yl]methyl]-2,2-dimethyl-3h-1-benzofuran-7-carboxamide Chemical compound O[C@@H]1CN(CCCOC)CC[C@H]1CNC(=O)C1=CC(Cl)=C(N)C2=C1OC(C)(C)C2 FOUUNSGQVBGYQM-SUMWQHHRSA-N 0.000 abstract 1
- 101001043818 Mus musculus Interleukin-31 receptor subunit alpha Proteins 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
- 125000006237 oxymethylenoxy group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- 125000003373 pyrazinyl group Chemical group 0.000 abstract 1
- 125000002098 pyridazinyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/12—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/16—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
A találmány tárgya (I) általános képletűvegyületek és sztereokémiaiizomer formájuk, N-oxidjuk vagy gyógyászatilag elfogadható savaddícióssóik - ahol R1 és R2 ielentése -O-C H2-O- -O-CH2-CH2- -O-CH2-CH2-O- -O-CH2-CH2-CH2- -O-CH2-CH2-CH2-O- -O-CH2-CH2-CH2-CH2- képletű kétértékűcsoportot képez, ahol a kétértékű csoportok egy vagy kéthidrogénatomját alkilcsoport helyettesíti; R3 jelentése hidrogén- vagyhalogénatom; R4 jelentése hidrogénatom vagy alkilcsoport; R5 jelentésehidrogénatom vagy alkilcsoport; L jelentése cikloalkil-, cikloalkanon-vagy alkenilcsoport, vagy L jelentése -Alk-R7 -Alk-X-R7 -Alk-Y-C(=O)-R9 Alk-Y-C(=O)-NR11R12 ahol mindegyik Alk 1-12 szénatomos alkán-diil-csoport. A találmány kiterjed a termékek előállítására, a vegyületekettartalmazó gyógyászati készítményekre és gyógyszerként történőalkalmazásukra, különösen a gyomorürülés romlásával kapcsolatosállapotok kezelésére. Ó
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97202180 | 1997-07-11 | ||
EP98200624 | 1998-02-27 | ||
PCT/EP1998/004190 WO1999002156A1 (en) | 1997-07-11 | 1998-07-07 | Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0002539A2 true HUP0002539A2 (hu) | 2000-12-28 |
HUP0002539A3 HUP0002539A3 (en) | 2002-03-28 |
HU227424B1 HU227424B1 (en) | 2011-05-30 |
Family
ID=26146699
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0002539A HU227424B1 (en) | 1997-07-11 | 1998-07-07 | Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates |
HU0004564A HUP0004564A3 (en) | 1997-07-11 | 1998-07-07 | Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives, process for producing them and pharmaceutical compositions containing them |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0004564A HUP0004564A3 (en) | 1997-07-11 | 1998-07-07 | Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives, process for producing them and pharmaceutical compositions containing them |
Country Status (34)
Country | Link |
---|---|
US (10) | US6452013B1 (hu) |
EP (3) | EP0991410B1 (hu) |
JP (2) | JP4530530B2 (hu) |
KR (2) | KR100885658B1 (hu) |
CN (2) | CN1117568C (hu) |
AR (2) | AR013361A1 (hu) |
AT (2) | ATE226820T1 (hu) |
AU (2) | AU747199B2 (hu) |
BG (2) | BG64230B1 (hu) |
BR (2) | BR9811687A (hu) |
CA (2) | CA2295087C (hu) |
CZ (2) | CZ297298B6 (hu) |
DE (2) | DE69820065T2 (hu) |
DK (2) | DK0991410T3 (hu) |
EA (1) | EA002619B1 (hu) |
EE (1) | EE04178B1 (hu) |
ES (2) | ES2187051T3 (hu) |
HK (2) | HK1025093A1 (hu) |
HR (2) | HRP20000005B1 (hu) |
HU (2) | HU227424B1 (hu) |
ID (2) | ID24161A (hu) |
IL (2) | IL133917A (hu) |
MY (2) | MY123199A (hu) |
NO (2) | NO314662B1 (hu) |
NZ (2) | NZ502208A (hu) |
PL (2) | PL190310B1 (hu) |
PT (2) | PT991410E (hu) |
RU (1) | RU2213089C2 (hu) |
SI (2) | SI1000028T1 (hu) |
SK (2) | SK284632B6 (hu) |
TR (2) | TR200000023T2 (hu) |
TW (2) | TW548103B (hu) |
UA (1) | UA67745C2 (hu) |
WO (2) | WO1999002494A1 (hu) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW548103B (en) * | 1997-07-11 | 2003-08-21 | Janssen Pharmaceutica Nv | Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
TW570920B (en) * | 1998-12-22 | 2004-01-11 | Janssen Pharmaceutica Nv | 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
US20040253179A1 (en) * | 2003-02-26 | 2004-12-16 | Acm Medical Technologies, Inc. | Measuring gastrointestinal parameters |
US20080219928A1 (en) * | 2003-02-26 | 2008-09-11 | Becker Jane A | Measuring Gastrointestinal Parameters |
WO2005003122A1 (en) * | 2003-06-19 | 2005-01-13 | Janssen Pharmaceutica N.V. | 5ht4-antagonistic 4-(aminomethyl)-piperidine benzamides |
ES2336448T3 (es) * | 2003-06-19 | 2010-04-13 | Janssen Pharmaceutica Nv | 4-(aminometil)-piperidina-benzamidas con sustituyentes heterociclicos como antagonistas de 5ht4. |
JO2478B1 (en) * | 2003-06-19 | 2009-01-20 | جانسين فارماسوتيكا ان. في. | (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists |
AU2004251823B2 (en) * | 2003-06-19 | 2010-06-03 | Janssen Pharmaceutica N.V. | Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists |
ATE388146T1 (de) | 2004-01-29 | 2008-03-15 | Pfizer | 1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor |
TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
WO2005092882A1 (en) * | 2004-03-01 | 2005-10-06 | Pfizer Japan, Inc. | 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders |
US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
TWI351282B (en) | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
DE602005016446D1 (de) * | 2004-11-05 | 2009-10-15 | Theravance Inc | 5-HT4-Rezeptoragonistenverbindungen |
ATE431824T1 (de) * | 2004-11-05 | 2009-06-15 | Theravance Inc | Chinolinon-carboxamid-verbindungen |
US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
PT2522365T (pt) | 2004-11-24 | 2017-02-08 | Meda Pharmaceuticals Inc | Composições que compreendem azelastina e seus métodos de utilização |
ES2347265T3 (es) * | 2004-12-22 | 2010-10-27 | Theravance, Inc. | Compuestos de indazol-carboxamida. |
KR20070107807A (ko) * | 2005-03-02 | 2007-11-07 | 세라밴스 인코포레이티드 | 5-ht4 수용체 아고니스트인 퀴놀리논 화합물 |
TWI377206B (en) * | 2005-04-06 | 2012-11-21 | Theravance Inc | Crystalline form of a quinolinone-carboxamide compound |
GB0603550D0 (en) * | 2006-02-22 | 2006-04-05 | Glaxo Group Ltd | Novel compounds |
US9654833B2 (en) | 2007-06-26 | 2017-05-16 | Broadband Itv, Inc. | Dynamic adjustment of electronic program guide displays based on viewer preferences for minimizing navigation in VOD program selection |
US8642772B2 (en) | 2008-10-14 | 2014-02-04 | Sk Biopharmaceuticals Co., Ltd. | Piperidine compounds, pharmaceutical composition comprising the same and its use |
US20110313319A1 (en) * | 2008-11-07 | 2011-12-22 | SAND COUNTY BIOTECHNOLOGY, Inc. | Measuring method for the concentration of intragastric contents |
US8232315B2 (en) | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
AU2010316106B2 (en) | 2009-11-06 | 2015-10-22 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating attention-deficit/hyperactivity disorder |
MX350745B (es) | 2009-11-06 | 2017-09-14 | Sk Biopharmaceuticals Co Ltd * | El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia. |
KR101180174B1 (ko) * | 2010-04-23 | 2012-09-05 | 동아제약주식회사 | 신규한 벤즈아미드 유도체 |
US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
JP6182989B2 (ja) | 2012-06-28 | 2017-08-23 | セントラル硝子株式会社 | 1,3,3,3−テトラフルオロプロペンの製造方法 |
WO2014083003A1 (en) | 2012-11-27 | 2014-06-05 | Shire International Gmbh | Pro-cognitive compound |
KR101595183B1 (ko) * | 2013-07-25 | 2016-02-17 | 동아에스티 주식회사 | 벤즈아미드 유도체의 제조방법, 그의 제조에 사용되는 새로운 중간체 및 상기 중간체의 제조방법 |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1046052B (it) * | 1973-10-12 | 1980-06-30 | Sigurta Farmaceutici Spa | Processo per la preparazione di i aralchil 4 aminometil piperidin 4 oli |
US4348763A (en) * | 1980-08-07 | 1982-09-07 | Hewlett-Packard Company | Multiple stripe leaky mode laser |
US4711703A (en) | 1982-02-03 | 1987-12-08 | Orbisphere Corporation Wilmington, Succursale De Collonge-Bellerive | Thermal protection method for electroanalytical cell |
DE3416224C2 (de) | 1983-05-06 | 1994-05-05 | Mitsubishi Chem Ind | Verfahren zur Herstellung eines Kohleverflüssigungsöls |
US4772630A (en) | 1984-11-23 | 1988-09-20 | Ciba-Geigy Corp. | Benzamides and their salts |
US4722630A (en) | 1985-09-20 | 1988-02-02 | The Garrett Corporation | Ceramic-metal braze joint |
GB8527052D0 (en) | 1985-11-02 | 1985-12-04 | Beecham Group Plc | Compounds |
US4910312A (en) | 1985-11-08 | 1990-03-20 | Warner-Lambert Company | Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof |
US4910193A (en) | 1985-12-16 | 1990-03-20 | Sandoz Ltd. | Treatment of gastrointestinal disorders |
US4746655A (en) * | 1987-06-10 | 1988-05-24 | A. H. Robins Company, Incorporated | Fused aromatic-spiropiperidine oxazepinones(and thiones) |
BE1000689A6 (fr) | 1987-07-14 | 1989-03-14 | Donnay Donnay S A Ets | Raquette de tennis, de squash ou sport analogue. |
US5130312A (en) | 1987-07-17 | 1992-07-14 | Janssen Pharmaceutica N.V. | Substituted N-(3-hydroxy-4-piperidinyl)benzamides |
NZ225152A (en) | 1987-07-17 | 1990-04-26 | Janssen Pharmaceutica Nv | Heterocyclically substituted piperidinyl benzamides as pharmaceuticals |
US4906643A (en) | 1987-07-17 | 1990-03-06 | Janssen Pharmaceutica N.V. | Substituted N-(3-hydroxy-4-piperidinyl)benzamides as gastrointestinal agents |
JPH0719937B2 (ja) * | 1987-09-24 | 1995-03-06 | 三井石油化学工業株式会社 | 高周波用積層板およびその製造方法 |
CA1317940C (en) | 1987-09-25 | 1993-05-18 | Georges H. P. Van Daele | Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
US4975439A (en) | 1987-09-25 | 1990-12-04 | Janssen Pharmaceutical N.V. | Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
US5041454A (en) | 1987-09-25 | 1991-08-20 | Janssen Pharmaceutica N.V. | Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
JP2573017B2 (ja) | 1988-03-08 | 1997-01-16 | 三洋電機株式会社 | ディスクプレーヤ |
US5053412A (en) | 1990-04-10 | 1991-10-01 | Israel Institute For Biological Research | Spiro nitrogen-bridged heterocyclic compounds |
US5374637A (en) * | 1989-03-22 | 1994-12-20 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
GB9005014D0 (en) | 1990-03-06 | 1990-05-02 | Janssen Pharmaceutica Nv | N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives |
US5103141A (en) | 1990-03-08 | 1992-04-07 | U.S. Philips Corporation | Switching arrangement for increasing the white life of a high pressure sodium lamp |
US5534520A (en) | 1990-04-10 | 1996-07-09 | Fisher; Abraham | Spiro compounds containing five-membered rings |
US5407938A (en) | 1990-04-10 | 1995-04-18 | Israel Institute For Biological Research | Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines) |
TW213460B (hu) * | 1991-02-15 | 1993-09-21 | Hokuriku Pharmaceutical | |
JPH06510283A (ja) | 1991-08-20 | 1994-11-17 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5−ht4レセプター拮抗薬 |
SG49153A1 (en) | 1991-09-12 | 1998-05-18 | Smithkline Beecham Plc | 5-HT4 receptor antagonists |
IT1252567B (it) * | 1991-12-20 | 1995-06-19 | Italfarmaco Spa | Derivati di 5-isochinolinsolfonammidi inibitori delle protein-chinasi |
WO1993013101A1 (en) * | 1991-12-27 | 1993-07-08 | Yoshitomi Pharmaceutical Industries, Ltd. | Pyridonecarboxylate compound, pharmaceutical use thereof, and spiro compound |
AU667874B2 (en) | 1992-02-06 | 1996-04-18 | Smithkline Beecham Plc | Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists |
JPH05236345A (ja) | 1992-02-21 | 1993-09-10 | Nec Ic Microcomput Syst Ltd | 画像用垂直フィルタ回路 |
MX9306311A (es) | 1992-10-13 | 1994-04-29 | Smithkline Beecham Plc | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen |
AU680453B2 (en) | 1992-11-05 | 1997-07-31 | Smithkline Beecham Plc | Piperidine derivatives as 5-HT4 receptor antagonists |
US6127379A (en) * | 1993-02-01 | 2000-10-03 | Smithkline Beecham P.L.C. | Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists |
WO1995026953A1 (fr) * | 1994-03-30 | 1995-10-12 | Yoshitomi Pharmaceutical Industries, Ltd. | Compose d'acide benzoïque et son utilisation comme medicament |
US5864039A (en) * | 1994-03-30 | 1999-01-26 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoic acid compounds and use thereof as medicaments |
TW490465B (en) * | 1994-11-24 | 2002-06-11 | Janssen Pharmaceutica Nv | Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof |
GB9507882D0 (en) * | 1995-04-18 | 1995-05-31 | Pharmacia Spa | Substituted dihydrobenzofuran derivatives as 5-ht4 agonists |
EP0873990A1 (en) * | 1995-09-22 | 1998-10-28 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoic acid compounds and medicinal use thereof |
US6096761A (en) * | 1996-02-15 | 2000-08-01 | Janssen Pharmaceutica N.V. | Esters of 3-hydroxy-piperidinemethanol derivatives |
KR100469029B1 (ko) * | 1996-02-15 | 2005-05-27 | 얀센 파마슈티카 엔.브이. | 세로토닌재흡수억제제의위장효과를극복하기위한5ht4수용체길항제의용도 |
TW548103B (en) | 1997-07-11 | 2003-08-21 | Janssen Pharmaceutica Nv | Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
EP0950243A1 (en) | 1997-10-31 | 1999-10-20 | Deawoo Electronics Co., Ltd. | Cd changer with a driving mechanism operated by a single driving source |
EP1112270B1 (en) * | 1998-09-10 | 2007-03-21 | F. Hoffmann-La Roche Ag | Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists |
-
1998
- 1998-06-12 TW TW087109331A patent/TW548103B/zh not_active IP Right Cessation
- 1998-06-12 TW TW087109332A patent/TW402591B/zh not_active IP Right Cessation
- 1998-07-07 WO PCT/EP1998/004189 patent/WO1999002494A1/en active IP Right Grant
- 1998-07-07 ID IDW2000030A patent/ID24161A/id unknown
- 1998-07-07 PT PT98940158T patent/PT991410E/pt unknown
- 1998-07-07 IL IL13391798A patent/IL133917A/xx not_active IP Right Cessation
- 1998-07-07 UA UA2000010195A patent/UA67745C2/uk unknown
- 1998-07-07 WO PCT/EP1998/004190 patent/WO1999002156A1/en active IP Right Grant
- 1998-07-07 SK SK1734-99A patent/SK284632B6/sk not_active IP Right Cessation
- 1998-07-07 EP EP98940158A patent/EP0991410B1/en not_active Expired - Lifetime
- 1998-07-07 KR KR1019997012486A patent/KR100885658B1/ko not_active IP Right Cessation
- 1998-07-07 RU RU2000103212/04A patent/RU2213089C2/ru active
- 1998-07-07 JP JP2000502022A patent/JP4530530B2/ja not_active Expired - Lifetime
- 1998-07-07 EP EP02075710A patent/EP1206938A1/en not_active Ceased
- 1998-07-07 CN CN98806950A patent/CN1117568C/zh not_active Expired - Lifetime
- 1998-07-07 AU AU88063/98A patent/AU747199B2/en not_active Expired
- 1998-07-07 CN CNB988069571A patent/CN1195736C/zh not_active Expired - Lifetime
- 1998-07-07 ID IDW20000036D patent/ID24481A/id unknown
- 1998-07-07 EE EEP200000015A patent/EE04178B1/xx unknown
- 1998-07-07 TR TR2000/00023T patent/TR200000023T2/xx unknown
- 1998-07-07 HU HU0002539A patent/HU227424B1/hu unknown
- 1998-07-07 DK DK98940158T patent/DK0991410T3/da active
- 1998-07-07 DK DK98939620T patent/DK1000028T3/da active
- 1998-07-07 NZ NZ502208A patent/NZ502208A/en unknown
- 1998-07-07 CA CA002295087A patent/CA2295087C/en not_active Expired - Lifetime
- 1998-07-07 PT PT98939620T patent/PT1000028E/pt unknown
- 1998-07-07 PL PL98338005A patent/PL190310B1/pl not_active IP Right Cessation
- 1998-07-07 KR KR10-1999-7012492A patent/KR100500372B1/ko not_active IP Right Cessation
- 1998-07-07 EA EA200000110A patent/EA002619B1/ru not_active IP Right Cessation
- 1998-07-07 NZ NZ502209A patent/NZ502209A/xx not_active IP Right Cessation
- 1998-07-07 AT AT98940158T patent/ATE226820T1/de active
- 1998-07-07 DE DE69820065T patent/DE69820065T2/de not_active Expired - Lifetime
- 1998-07-07 AT AT98939620T patent/ATE255092T1/de not_active IP Right Cessation
- 1998-07-07 SI SI9830579T patent/SI1000028T1/xx unknown
- 1998-07-07 CZ CZ0463899A patent/CZ297298B6/cs not_active IP Right Cessation
- 1998-07-07 TR TR2000/00022T patent/TR200000022T2/xx unknown
- 1998-07-07 PL PL98338008A patent/PL190611B1/pl unknown
- 1998-07-07 CZ CZ19994587A patent/CZ295506B6/cs not_active IP Right Cessation
- 1998-07-07 EP EP98939620A patent/EP1000028B1/en not_active Expired - Lifetime
- 1998-07-07 AU AU88574/98A patent/AU734475B2/en not_active Expired
- 1998-07-07 BR BR9811687-8A patent/BR9811687A/pt active Search and Examination
- 1998-07-07 DE DE69809050T patent/DE69809050T2/de not_active Expired - Lifetime
- 1998-07-07 SI SI9830311T patent/SI0991410T1/xx unknown
- 1998-07-07 ES ES98940158T patent/ES2187051T3/es not_active Expired - Lifetime
- 1998-07-07 IL IL13391898A patent/IL133918A/en not_active IP Right Cessation
- 1998-07-07 JP JP50812599A patent/JP2002508000A/ja active Pending
- 1998-07-07 HU HU0004564A patent/HUP0004564A3/hu unknown
- 1998-07-07 US US09/462,287 patent/US6452013B1/en not_active Expired - Lifetime
- 1998-07-07 SK SK1840-99A patent/SK284942B6/sk not_active IP Right Cessation
- 1998-07-07 CA CA002295088A patent/CA2295088C/en not_active Expired - Lifetime
- 1998-07-07 BR BRPI9811688 patent/BRPI9811688B8/pt not_active IP Right Cessation
- 1998-07-07 ES ES98939620T patent/ES2212330T3/es not_active Expired - Lifetime
- 1998-07-08 MY MYPI98003106A patent/MY123199A/en unknown
- 1998-07-08 MY MYPI98003107A patent/MY117803A/en unknown
- 1998-07-10 AR ARP980103374A patent/AR013361A1/es active IP Right Grant
- 1998-07-10 AR ARP980103373A patent/AR016324A1/es active IP Right Grant
-
1999
- 1999-12-10 BG BG103984A patent/BG64230B1/bg unknown
- 1999-12-10 BG BG103983A patent/BG63709B1/bg unknown
-
2000
- 2000-01-05 HR HR20000005A patent/HRP20000005B1/xx not_active IP Right Cessation
- 2000-01-05 HR HR20000006A patent/HRP20000006B1/xx not_active IP Right Cessation
- 2000-01-10 NO NO20000115A patent/NO314662B1/no not_active IP Right Cessation
- 2000-01-10 NO NO20000116A patent/NO317467B1/no not_active IP Right Cessation
- 2000-07-08 HK HK00104201A patent/HK1025093A1/xx not_active IP Right Cessation
- 2000-07-08 HK HK00104203A patent/HK1025047A1/xx not_active IP Right Cessation
-
2001
- 2001-02-22 US US09/791,227 patent/US6635643B2/en not_active Ceased
-
2002
- 2002-06-05 US US10/162,802 patent/US6750349B2/en not_active Expired - Lifetime
-
2003
- 2003-08-19 US US10/643,506 patent/US20040058958A1/en not_active Abandoned
-
2005
- 2005-10-26 US US11/259,719 patent/USRE40793E1/en not_active Expired - Lifetime
-
2006
- 2006-02-16 US US11/355,326 patent/US20060142341A1/en not_active Abandoned
- 2006-02-17 US US11/357,884 patent/US20060142342A1/en not_active Abandoned
- 2006-10-20 US US11/584,732 patent/US7790750B2/en not_active Expired - Fee Related
-
2010
- 2010-05-04 US US12/773,183 patent/US8063070B2/en not_active Expired - Fee Related
-
2011
- 2011-09-20 US US13/237,330 patent/US8318742B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0002539A2 (hu) | Gasztrokinetikus hatású 3- vagy 4-szubsztituált 4-(amino-metil)-piperidin-származékok biciklusos benzamidjai, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
CN100497334C (zh) | 用作组胺h3拮抗剂的吲哚衍生物 | |
HUT60733A (en) | Process for producing new n-(4-piperidinyl)-(dihydrobenzofuran or dihydro-2h-benzopyran)-carboxamide derivatives and pharmaceutical compositions comprising such compounds | |
RU2000103212A (ru) | Моноциклические бензамиды производных 3- или 4-замещенного 4-(аминометил)пиперидина с гастрокинетическими свойствами | |
MY121852A (en) | 4-(aminoethyl)-piperidine benzamides for treating gastrointestinal disorders | |
RU2016118619A (ru) | Селективно замещенные соединения хинолина | |
CA2376676A1 (en) | Respiratory syncytial virus replication inhibitors | |
IL115040A (en) | Substituted piperidines useful for the treatment of allergic diseases process for their preparation and pharmaceutical compositions containing them | |
CA2238818A1 (en) | 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists | |
DE60004564D1 (de) | Neue piperidin und piperazin-derivate als p2x7-rezeptor antagonisten | |
BG104372A (en) | (benzodioxan, benzofuran or benzopyran) derivatives possessing fundus relaxing properties | |
JP2006512412A5 (ja) | 神経系の疾患の治療用のベンズアゼピン誘導体 | |
JP2012512255A5 (hu) | ||
CN101203510A (zh) | 用作组胺h3拮抗剂的碳连接的取代哌啶及其衍生物 | |
KR100566470B1 (ko) | 뉴로키닌-1 길항물질로서의 피페리딘 유도체 | |
KR20080039990A (ko) | 선택적 cgrp 길항제, 이의 제조 방법 및 이의약제로서의 용도 | |
JP2008526878A5 (hu) | ||
HK1018065A1 (en) | Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases | |
KR20120101543A (ko) | 피롤리딘 유도체 | |
TR200001262T2 (tr) | Alzheimer tipi yaşlılık demansının tedavisi için aktif muhteviyatların kombinasyonu | |
CN117813307A (zh) | 白介素-1受体相关激酶的双官能降解物及其治疗用途 | |
CO4970750A1 (es) | BENZAMIDAS BICICLICAS DE DERIVADOS 3-o 4-SUBSTITUIDOS 4- (AMINOMETIL)-PIPERIDINAS | |
GB1307277A (en) | 1-carbamoyl-4-phenylpiperidines and tetrahydropyridines | |
TH45377A (th) | ไบไซคลิกเบนซาไมด์ของอนุพันธ์ 4-(อะมิโนเมทิล)-พิเพอริดีน ซึ่งได้รับการแทนที่ที่ 3 หรือ 4 | |
TH29792B (th) | ไบไซคลิกเบนซาไมด์ของอนุพันธ์ 4-(อะมิโนเมทิล)-พิเพอริดีน ซึ่งได้รับการแทนที่ที่ 3 หรือ 4 |